Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind, Multicenter Placebo-controlled Study Evaluating Neurotoxicity in Patients With Metastatic Gastro Intestinal Cancer Taking Phycocare® or Placebo During Oxaliplatin Based Chemotherapy

NCT05025826 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT05025826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05025826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind, Multicenter Placebo-controlled Study Evaluating Neurotoxicity in Patients With Metastatic Gastro Intestinal Cancer Taking Phycocare® or Placebo During Oxaliplatin Based Chemotherapy
Lead sponsor
Nantes University Hospital
Phase
Not applicable
Overall status
Completed
Start date
April 1, 2022
Completion date
April 14, 2026
Enrollment
73 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic gastric cancer